SMTL ID : 5kq5.1

AMPK bound to allosteric activator

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.41 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x STU: STAUROSPORINE(Non-covalent)

STU.1: 18 residues within 4Å: Chain A: L.24, G.25, V.26, G.27, V.32, A.45, I.79, M.95, E.96, Y.97, V.98, G.101, E.102, E.145, N.146, L.148, A.158, D.159 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:L.24, A:V.32, A:V.32, A:A.45, A:Y.97, A:E.102, A:L.148, A:L.148 Hydrogen bonds: A:V.98, A:E.145

1 x 6VT: 6-chloranyl-5-[4-(1-oxidanylcyclobutyl)phenyl]-1~{H}-indole-3-carboxylic acid(Non-covalent)

6VT.2: 15 residues within 4Å: Chain A: V.13, L.20, G.21, K.31, K.33, I.48, D.90, F.92 Chain B: V.15, R.17, T.40, D.42, N.45, V.47, I.49 14 PLIP interactions: 8 interactions with chain A, 6 interactions with chain B Hydrophobic interactions: A:V.13, A:V.13, A:L.20, A:K.33, A:I.48, B:T.40, B:D.42, B:V.47, B:V.47 Hydrogen bonds: A:D.90 Salt bridges: A:K.31, B:R.17 pi-Cation interactions: A:K.33, B:R.17

4 x CL: CHLORIDE ION(Non-functional Binders)

CL.3: 3 residues within 4Å: Chain A: S.99, D.150, A.151 Ligand excluded by PLIP CL.4: 0 residues within 4Å: (No contacts) Ligand excluded by PLIP CL.5: 2 residues within 4Å: Chain A: G.25, V.26 Ligand excluded by PLIP CL.6: 2 residues within 4Å: Chain A: K.36, K.43 Ligand excluded by PLIP

2 x AMP: ADENOSINE MONOPHOSPHATE(Non-covalent)

AMP.7: 14 residues within 4Å: Chain C: H.150, T.199, I.203, A.204, V.224, S.225, A.226, P.228, H.297, R.298, I.311, S.313, S.315, D.316 12 PLIP interactions: 12 interactions with chain C Hydrogen bonds: C:T.199, C:A.204, C:A.204, C:S.225, C:S.225, C:S.225, C:R.298, C:S.313, C:S.315, C:D.316 Salt bridges: C:H.150, C:H.297 AMP.8: 12 residues within 4Å: Chain C: R.69, I.239, S.241, F.243, D.244, R.268, L.276, V.296, H.297, R.298, L.299 Ligands: SO4.10 10 PLIP interactions: 10 interactions with chain C Hydrogen bonds: C:S.241, C:D.244, C:R.268, C:R.268, C:L.276, C:L.276, C:H.297, C:R.298 Salt bridges: C:R.69, C:R.298

1 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)

ADP.9: 15 residues within 4Å: Chain C: R.69, M.84, T.86, I.87, T.88, D.89, Y.120, P.127, L.128, V.129, I.149, H.150, R.151, P.153, K.242 15 PLIP interactions: 15 interactions with chain C Hydrogen bonds: C:I.87, C:T.88, C:D.89, C:Y.120, C:Y.120, C:V.129, C:H.150, C:R.151, C:R.151 Salt bridges: C:R.69, C:H.150, C:H.150, C:R.151, C:K.242, C:K.242

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.10: 4 residues within 4Å: Chain C: R.151, T.167, K.169 Ligands: AMP.8 1 PLIP interactions: 1 interactions with chain C Salt bridges: C:R.151

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Cameron, K.O. et al., Discovery and Preclinical Characterization of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic Acid (PF-06409577), a Direct Activator of Adenosine Monophosphate-activated Protein Kinase (AMPK), for the Potential Treatment of Diabetic Nephropathy. J.Med.Chem. (2016)

Release Date

2016-08-17

Peptides

5'-AMP-activated protein kinase catalytic subunit alpha-1: A
5'-AMP-activated protein kinase subunit beta-1: B
5'-AMP-activated protein kinase subunit gamma-1: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

5'-AMP-activated protein kinase catalytic subunit alpha-1

5'-AMP-activated protein kinase subunit beta-1

5'-AMP-activated protein kinase subunit gamma-1

Related Entries With Identical Sequence